Allianz Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,000
Closed -$512K 1695
2024
Q1
$512K Sell
7,000
-3,000
-30% -$219K ﹤0.01% 1419
2023
Q4
$714K Buy
10,000
+2,900
+41% +$207K ﹤0.01% 1312
2023
Q3
$425K Hold
7,100
﹤0.01% 1491
2023
Q2
$512K Buy
+7,100
New +$512K ﹤0.01% 1305
2021
Q2
Sell
-4,016
Closed -$382K 1960
2021
Q1
$382K Buy
+4,016
New +$382K ﹤0.01% 1744
2019
Q1
Sell
-62,927
Closed -$5.33M 2265
2018
Q4
$5.33M Buy
62,927
+33,616
+115% +$2.85M 0.01% 1143
2018
Q3
$5.02M Buy
29,311
+4,421
+18% +$757K ﹤0.01% 1264
2018
Q2
$3.22M Sell
24,890
-19,516
-44% -$2.52M ﹤0.01% 1366
2018
Q1
$4.58M Sell
44,406
-17,290
-28% -$1.78M ﹤0.01% 1244
2017
Q4
$5.27M Sell
61,696
-26,977
-30% -$2.3M ﹤0.01% 1198
2017
Q3
$7.53M Sell
88,673
-21,052
-19% -$1.79M 0.01% 1058
2017
Q2
$8.31M Buy
109,725
+6,790
+7% +$514K 0.01% 1035
2017
Q1
$6.8M Sell
102,935
-21,684
-17% -$1.43M 0.01% 1117
2016
Q4
$7.9M Sell
124,619
-84,120
-40% -$5.33M 0.01% 1077
2016
Q3
$13.3M Buy
208,739
+3,569
+2% +$227K 0.01% 888
2016
Q2
$15.3M Sell
205,170
-211,636
-51% -$15.7M 0.02% 792
2016
Q1
$27.8M Buy
416,806
+11,678
+3% +$780K 0.03% 542
2015
Q4
$27.4M Buy
405,128
+52,372
+15% +$3.54M 0.03% 543
2015
Q3
$18.8M Sell
352,756
-73,256
-17% -$3.91M 0.02% 661
2015
Q2
$26.8M Sell
426,012
-149,366
-26% -$9.4M 0.03% 588
2015
Q1
$27.7M Sell
575,378
-81,501
-12% -$3.92M 0.03% 524
2014
Q4
$21.8M Buy
656,879
+17,149
+3% +$569K 0.02% 585
2014
Q3
$18.6M Buy
639,730
+194,155
+44% +$5.66M 0.02% 613
2014
Q2
$17.3M Sell
445,575
-2,994
-0.7% -$116K 0.02% 595
2014
Q1
$18.7M Buy
448,569
+62,692
+16% +$2.61M 0.02% 564
2013
Q4
$12.7M Buy
385,877
+100,854
+35% +$3.31M 0.02% 641
2013
Q3
$7.7M Buy
285,023
+12,353
+5% +$334K 0.01% 757
2013
Q2
$6.36M Buy
+272,670
New +$6.36M 0.01% 786